The relation of serum calprotectin, angiopoietin-1 and angiopoietin-2 levels with coronary collateral circulation in patients with stable coronary artery disease.
Backround: In patients with chronic stable coronary artery disease (CAD), well-developed coronary collateral circulation (CCC) is known to reduce long-term mortality. The objective of this study was to determine the relationship of serum calprotectin (S100A8 / S100A9), angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) concentrations with CCC in patients with stable CAD. This cross-sectional and prospective study included 147 patients with stable angina pectoris. Cohen-Rentrop classification was made for collateral circulation of patients. Patients were divided into two groups as patients with poor CCC (Cohen-Rentrop score 0 and 1) (n = 79) and patients with good CCC (Cohen-Rentrop score 2 and 3) (n = 68). Groups were compared for serum calprotectin, Ang-1 and Ang-2 concentrations. Compared with the good CCC group, serum calprotectin (p<0.01) and Ang-1 (p<0.001) levels were significantly higher, while serum Ang-2 (p<0.01) levels were significantly lower in the poor CCC group. C-reactive protein (CRP) values showed a moderate positive correlation with calprotectin values (r = 0.359; p <0.001). In the multivariate regression analysis, only calprotectin (p<0.05) and Ang-1 (p<0.05) were found to be independent factors for the presence of good and poor CCC. In this study, it was determined that Ang-2 values were lower and serum calprotectin and Ang-1 values were higher in stable CAD patients with poor CCC regardless of the complexity and severity of coronary arteriosclerosis. If these results are confirmed in future studies, calprotectin may be a biomarker that needs to be investigated to guide anti-ischemic treatment.